Gauthami Pulivendala

Statistics

Publications

Citations

264

H-Index

Active since

2018

Affiliations

National Institute of Pharmaceutical Education and Research - Ahmedabad(Current)

National Institute of Pharmaceutical Education and Research

Gauthami Pulivendala is an author at National Institute of Pharmaceutical Education and Research - Ahmedabad specializing in fibrosis, inflammation, and pharmacology.

Publications per year

2018–2021

Publications

Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo

Gauthami Pulivendala, Swarna Bale, Chandraiah Godugu · Toxicology and Applied Pharmacology · 2020 · 50 citations

Life Sciences, Pathobiology, Pharmacology +17

Ferulic acid ameliorates the progression of pulmonary fibrosis via inhibition of TGF-β/smad signalling

Syed Afroz Ali, Mohd Aslam Saifi, Gauthami Pulivendala et al. · Food and Chemical Toxicology · 2021 · 46 citations

Medicine, Molecular Medicine, Pharmacology +12

Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt/β-catenin signaling: A drug repurposing study

Raju Boyapally, Gauthami Pulivendala, Swarna Bale et al. · Life Sciences · 2019 · 43 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +15

Synthesis and evaluation of new 4(3H)-Quinazolinone derivatives as potential anticancer agents

Srikanth Gatadi, Gauthami Pulivendala, Jitendra Gour et al. · Journal of Molecular Structure · 2019 · 37 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Withaferin A attenuates bleomycin‐induced scleroderma by targeting FoxO3a and NF‐κβ signaling: Connecting fibrosis and inflammation

Swarna Bale, Gauthami Pulivendala, Chandraiah Godugu · BioFactors · 2018 · 34 citations

Medicine, Pathobiology, Pathology +17

1–5 of 7